Aging and Aging-associated Diseases: a MicroRNA-based Endocrine Regulation Hypothesis
Overview
Authors
Affiliations
Although there are numerous hypotheses explaining the nature of aging and associated processes, two concepts are dominant: (i) aging is a result of cell-autonomous processes, such as the accumulation of DNA mutations, aberrant methylations, protein defects, and shortening of telomeres, leading to either inhibition of cellular proliferation and death of non-dividing terminally differentiated cells or tumor development; (ii) aging is a result of a central program that is switched on at a specific stage of organismic development. The microRNA-based endocrine regulation hypothesis combines the two above concepts by proposing central regulation of cell death occurrences via hypothalamus-pituitary gland (PG)-secreted miRNA hormones, the expression and/or secretion of which are regulated by sex hormones. This hypothesis explains such well-known phenomena as inverse comorbidity of either cancer or Alzheimer's (AD) and other neurodegenerative diseases; higher AD morbidity and lower frequency of many common types of cancer in women vs. men; higher risk of early AD and lower risk of cancer in subjects with Down syndrome; longer life expectancy in women vs. men and much lower sex-dependent differences, if any, in other mammals; increased lifespans due to hypophysectomy or PG hypofunction; and parabiotic effects of blood or plasma transfusions between young and old animals.
Krarup J, Araya L, Alvarez F, Borquez D, Urrutia P Int J Mol Sci. 2024; 25(10).
PMID: 38791505 PMC: 11122052. DOI: 10.3390/ijms25105467.
Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility.
Caserta S, Gangemi S, Murdaca G, Allegra A Int J Mol Sci. 2023; 24(14).
PMID: 37511303 PMC: 10380791. DOI: 10.3390/ijms241411544.
Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment.
Kunwar A, Ablordeppey K, Mireskandari A, Sheinerman K, Kiefer M, Umansky S Diagnostics (Basel). 2023; 13(13).
PMID: 37443567 PMC: 10340136. DOI: 10.3390/diagnostics13132170.
Editorial: MicroRNAs in endocrinology and cell signaling.
Peng C, Li J Front Endocrinol (Lausanne). 2023; 13:1118426.
PMID: 36601018 PMC: 9806391. DOI: 10.3389/fendo.2022.1118426.
MiRNA-145-5p expression and prospective molecular mechanisms in the metastasis of prostate cancer.
Huang Z, Sun Y, Chen G, Dang Y, Lu H, He J IET Syst Biol. 2021; 15(1):1-13.
PMID: 33527765 PMC: 8675798. DOI: 10.1049/syb2.12011.